All stock reports

DALMIASUG evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-06T04:32:08.924214+00:00

Metrics

latest_annual_period
2026-03-31
revenue
36180800000.0
net_income
2367100000.0
operating_cash_flow
2169300000.0
free_cash_flow
925600000.0
total_assets
55210100000.0
total_liabilities
22860200000.0
total_equity
32424200000.0
cash
3317100000.0
total_debt
18031700000.0
revenue_growth
-0.034091697857322134
earnings_growth
-0.387950872656755
net_margin
0.0654242028921417
roe
0.07300411421099055
debt_to_equity
0.5561185780990742
cash_conversion
0.9164378353259263
free_cash_flow_margin
0.025582629460929554
trailing_pe
14.387
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
1.0095
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-f13bf750cc02c3df52f490e7420c7c52e0df5a8950052d8687de06a8c6237eb5
Policy
stock-decisions-v1
Evidence bundle hash
de13f646bc1b79d9d843805d94fe76087f65dd433d9e661989a731a24dc1bb5d
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: ecbb97e4c35258e62aa06416fdbfd02e2c42863a69a72783d297217a30fe8d86
  • daily-price: 5cbc435ad93f28e0f85dfd5ff760e4cf57e088def7df3b5f36081caa8a96ca27
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is -0.034091697857322134. The cached financial metric net margin is 0.0654242028921417. The cached financial metric roe is 0.07300411421099055. The cached financial metric debt to equity is 0.5561185780990742. The cached financial metric cash conversion is 0.9164378353259263.

Risks

The trailing 20-session price return was -13.11%. The closing price was -21.92% below its highest close in the available trailing year. The cached financial metric free cash flow margin is 0.025582629460929554. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Average cached traded value over twenty sessions was INR 103,242,395. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-06T04:32:08.924214+00:00 from EODHD.

Cached observations and evidence limits